US5998380A
(en)
|
1995-10-13 |
1999-12-07 |
New England Medical Center Hospitals, Inc. |
Treatment of migraine
|
KR970027051A
(ko)
*
|
1995-11-02 |
1997-06-24 |
조규향 |
카바모일기를 포함하는 신규한 설파메이트 화합물
|
US5892088A
(en)
*
|
1995-11-02 |
1999-04-06 |
Yukong Limited |
Sulfamate compound containing N-substituted carbamoyl group and method for preparing the same
|
US5952187A
(en)
*
|
1995-12-01 |
1999-09-14 |
Oxis International, Inc. |
Topiramate immunoassay
|
US5753694A
(en)
*
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
|
US5753693A
(en)
*
|
1996-06-28 |
1998-05-19 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
|
AU782344C
(en)
*
|
1999-04-08 |
2006-08-17 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
|
US6486198B1
(en)
*
|
1999-05-28 |
2002-11-26 |
Jeffrey Berlant |
Compounds and methods for the treatment of post traumatic stress disorder
|
US7674776B2
(en)
|
1999-06-14 |
2010-03-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
US20080255093A1
(en)
*
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
EP2305228B1
(de)
|
1999-06-14 |
2015-05-06 |
Vivus, Inc. |
Kombinationstherapie zur Behandlung von Hyperlipidämie bei Fettleibigkeit
|
US20080103179A1
(en)
*
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
DE10027887A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Jenapharm Gmbh |
Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
EP1309324B1
(de)
*
|
2000-07-07 |
2006-03-22 |
Ortho-McNeil Pharmaceutical, Inc. |
Antikonvulsive derivate zur behandlung und vorbeugung der entwicklung von typ ii diabetes und syndrom x
|
RU2003112618A
(ru)
*
|
2000-10-30 |
2004-09-27 |
Орто-Макнейл Фармасьютикал, Инк. (Us) |
Комбинированная терапия, включающая антидиабетические и противосудорожные средства
|
EP1345602B1
(de)
*
|
2000-11-30 |
2010-07-21 |
Novodermix International Limited |
Heilung von wunden
|
PT1471871E
(pt)
*
|
2001-02-02 |
2007-06-05 |
Ortho Mcneil Pharm Inc |
Tratamento de disfunção neurológica compreendendo sulfamatos de frutopiranose e eritropoietina
|
US7041650B2
(en)
|
2001-07-09 |
2006-05-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivative salts
|
UA78211C2
(en)
*
|
2001-07-09 |
2007-03-15 |
Ortho Mcneil Pharm Inc |
Salts of fructopyranose derivatives as anticonvulsant
|
US20030092636A1
(en)
*
|
2001-11-06 |
2003-05-15 |
Silberstein Stephen D. |
Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
|
US20030144347A1
(en)
*
|
2001-11-14 |
2003-07-31 |
Ralph Ryback |
Method for treating autoimmune disease
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US20030224006A1
(en)
|
2002-03-01 |
2003-12-04 |
Zaworotko Michael J. |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
US6559293B1
(en)
*
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
CN100352506C
(zh)
*
|
2002-02-26 |
2007-12-05 |
奥索-麦克尼尔药品公司 |
抗惊厥剂衍生物和抗偏头痛药物联合的制药用途
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
JP2006500377A
(ja)
*
|
2002-06-21 |
2006-01-05 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
改善された溶解性を有する医薬組成物
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
US7534780B2
(en)
|
2004-05-21 |
2009-05-19 |
Bayer Schering Pharma Aktiengesellschaft |
Estradiol prodrugs
|
TW200612905A
(en)
*
|
2004-06-16 |
2006-05-01 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
AU2005277134A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Janssen Pharmaceutica N.V. |
Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
|
JP2008545650A
(ja)
*
|
2005-05-20 |
2008-12-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファミド誘導体の製造方法
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
ATE458480T1
(de)
*
|
2005-09-23 |
2010-03-15 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl-pyrazol-cannabinoid- modulatoren
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
BRPI0616263A2
(pt)
|
2005-09-23 |
2011-06-14 |
Janssen Pharmaceutica Nv |
moduladores canabinàides do tipo tetrahidro-ciclopentil pirazol
|
PL1937259T3
(pl)
*
|
2005-09-23 |
2012-04-30 |
Janssen Pharmaceutica Nv |
Heksahydrocykloheptapirazolowe modulatory receptora kanabinoidowego
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
US8716231B2
(en)
*
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
US8492431B2
(en)
*
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
US20070155824A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
|
US8691867B2
(en)
*
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
EP1979593B1
(de)
*
|
2006-02-03 |
2017-12-06 |
Rolls-Royce Corporation |
Gasturbinenantriebsstoffsystem mit treibstoffmessendem ventil
|
WO2007095513A1
(en)
*
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
|
US20070191450A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
|
US20070191449A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
US20070191451A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
|
US20070191461A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
|
US20070191460A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
WO2007112402A1
(en)
*
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
EA200870556A1
(ru)
*
|
2006-05-19 |
2009-06-30 |
Янссен Фармацевтика Н.В. |
Комбинированная терапия в лечении эпилепсии и родственных расстройств
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
CN101855218A
(zh)
|
2007-09-13 |
2010-10-06 |
康塞特医药品有限公司 |
氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
US20090247616A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
|
US8580298B2
(en)
|
2008-06-09 |
2013-11-12 |
Vivus, Inc. |
Low dose topiramate/phentermine composition and methods of use thereof
|
US20090304789A1
(en)
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
NZ590682A
(en)
|
2008-06-23 |
2012-09-28 |
Janssen Pharmaceutica Nv |
Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
US20110244057A1
(en)
*
|
2008-09-25 |
2011-10-06 |
Ehrenberg Bruce L |
Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
|